2024-09-20 11:59 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. |
2024-08-05 08:01 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team |
2024-07-26 08:01 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million |
2024-07-09 08:05 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Special Cash Dividend |
2024-06-27 08:00 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale |
2024-05-29 16:05 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q |
2024-04-23 16:05 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K |
2024-03-06 08:05 | UU:MEDS | | News Release200 | TRxADE Health, Inc. Announces Special Cash Dividend |
2024-01-17 09:07 | UU:MEDS | | News Release200 | Trxade health, Inc files its 3Q 10Q |
2023-11-29 18:13 | UU:MEDS | | News Release200 | TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. |
2023-10-17 08:05 | UU:MEDS | | News Release200 | TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023. |
2023-10-12 08:05 | UU:MEDS | | News Release200 | Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales |
2023-10-04 08:05 | UU:MEDS | | News Release200 | Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, ‚ a plant-based tech company Disrupting the Dairy and Egg Industry. |